Three BriaCell poster presentations include updated key biomarker data from BriaCell’s pivotal Phase 3 study and updated survival data from…
First Patient Dosed at The Ohio State University Wexner Medical Center in this Multi-Center Trial Active component of HCW9302 is…
- Company to host conference call Today, November 18th at 11am ET/8am PT –NOT FOR DISTRIBUTION IN THE UNITED STATES OR…
Move a Key Commercialization CatalystDENVER, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories (OTCQB: KBLB) (“Kraig Labs” or “the…
PRESS RELEASE New operating system enables scientists to move from copilot to autopilot, unifying diverse in silico, wet lab research…
EDAP to Present at Piper Sandler 37th Annual Healthcare Conference Company to Present and Host 1x1 Investor Meetings on Tuesday,…
NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in…
Pivotal Phase III liver cancer study enrolling in Europe and Israel RAMAT GAN, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) --…
Project discussion at Charité The founder of aiomics speaking about the implementation assessment with Professor Akira Sebastian-Poncette and MD student…
LA JOLLA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…